Describes the medication bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, Zyban, Aplenzin, Forfivo XL) an antidepressant drug used to manage depression, and also to help with smoking cessation.
Advise families and caregivers of patients to observe for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt. Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms.
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication. Advise patients, families and caregivers that quitting smoking, with or without ZYBAN, may trigger nicotine withdrawal symptoms e. Some patients have experienced changes in mood including depression and mania , psychosis, hallucinations, paranoia, delusions, homicidal ideation, aggression, anxiety, and panic, as well as suicidal ideation, suicide attempt, and completed suicide when attempting to quit smoking while taking ZYBAN.
If patients develop agitation, hostility, depressed mood, or changes in thinking or behavior that are not typical for them, or if patients develop suicidal ideation or behavior, they should be urged to report these symptoms to their healthcare provider immediately. Advise patients to minimize or avoid the use of alcohol. Pre-existing glaucoma is almost always open-angle glaucoma because angle-closure glaucoma, when diagnosed, can be treated definitively with iridectomy.
Open-angleglaucoma is not a risk factor for angle-closure glaucoma. Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure e. In addition, there are a number of generic bupropion HCl products for the immediate, sustained, and extended-release formulations. Pregnancy Advise patients to notify their healthcare provider if they become pregnant or intend to become pregnant during therapy. Precautions For Nursing Mothers Communicate with the patient and pediatric healthcare provider regarding the infant's exposure to bupropion through human milk.
Instruct patients to immediately contact the infant's healthcare provider if they note any side effect in the infant that concerns them or is persistent. Instruct patients if they miss a dose, not to take an extra tablet to make up for the missed dose and to take the next tablet at the regular time because of the dose-related risk of seizure. The question of whether or not such lesions may be precursors of neoplasms of the liver is currently unresolved.
Similar liver lesions were not seen in the mouse study, and no increase in malignant tumors of the liver and other organs was seen in either study. Bupropion produced a positive response 2 to 3 times control mutation rate in 2 of 5 strains in one Ames bacterial mutagenicity assay, but was negative in another.
Bupropion produced an increase in chromosomal aberrations in 1 of 3 in vivo rat bone marrow cytogenetic studies. Use In Specific Populations Pregnancy Category C Risk Summary Data from epidemiological studies including pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations overall. No clear evidence of teratogenic activity was found in reproductive developmental studies conducted in rats and rabbits.
However, in rabbits, slightly increased incidences of fetal malformations and skeletal variations were observed at doses approximately equal to the maximum recommended human dose MRHD and greater and decreased fetal weights were seen at doses twice the MRHD and greater. Clinical Considerations Consider the risk of untreated depression when discontinuing or changing treatment with antidepressant medications during pregnancy and postpartum.
Human Data Data from an international bupropion Pregnancy registry first trimester exposures and a retrospective cohort study using the United Healthcare database 1, first trimester exposures did not show an increased risk for malformations overall. No increased risk for cardiovascular malformations overall has been observed after bupropion exposure during the first trimester. The prospectively observed rate of cardiovascular malformations in pregnancies with exposure to bupropion in the first trimester from the international Pregnancy Registry was 1.
Data from the United Healthcare database and a case-controlled study 6, infants with cardiovascular malformations and 5, with non-cardiovascular malformations from the National Birth Defects Prevention Study NBDPS did not show an increased risk for cardiovascular malformations overall after bupropion exposure during the first trimester. Study findings on bupropion exposure during the first trimester and risk left ventricular outflow tract obstruction LVOTO are inconsistent and do not allow conclusions regarding possible association.
Study findings on bupropion exposure during the first trimester and risk for ventricular septal defect VSD are inconsistent and do not allow conclusions regarding a possible association. For the findings of LVOTO and VSD, the studies were limited by the small number of exposed cases, inconsistent findings among studies, and the potential for chance findings from multiple comparisons in case control studies.
Nursing Mothers Bupropion and its metabolites are present in human milk. In a lactation study of ten women, levels of orally dosed bupropion and its active metabolites were measured in expressed milk. Pediatric Use Safety and effectiveness in the pediatric population have not been established.
No overall differences in safety or effectiveness were observed between these subjects and younger subjects. Reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Bupropion is extensively metabolized in the liver to active metabolites, which are further metabolized and excreted by the kidneys. Considered in isolation, bupropion was not statistically different from placebo. According to a Cochrane review , while there is an association with suicide it is unclear if bupropion was the cause. Some people, according to the advisory, have become depressed or have had their depression worsen, have had thoughts about suicide or dying, or have attempted suicide.
In most cases these symptoms can be reduced or eliminated by reducing the dose, ceasing treatment or adding antipsychotic medication.
When bupropion was one of several kinds of pills taken in an overdose, fever, muscle rigidity, muscle damage, hypertension or hypotension, stupor, coma, and respiratory failure have been reported. While most people recover, some people have died, and before they died suffered multiple uncontrolled seizures and heart attacks. I had gout in my feet never in my elbow until my sister mentioned that it sounds like gout and from the feeling and redness with the pain, it is what I felt years ago when I was drinking.
On the third week the doctor increased it to mg. Today is the 3rd day on mg, and the first time I feel anything, and its horrible. I can't move, no energy, horrible saddness, can't do anything. Hope I feel better soon. I was put on the extended release formula about 4yrs ago , and it's been great!!! I take mgs XR in the morning. It does a few things for me.
After about 4 days on it by energy was so much better I was like a new man. My doctor told me it would also carry my ADHD med longer as well as my painkillers.
I was able to reduce my ADHD med a bit. I have had a couple of good panic attacks from it's stimulation, but well worth it to me. No weight gain at all. Insomnia may also be dose-dependent. Insomnia may be minimized by reducing the dosage or avoiding administration at bedtime. Grand mal seizures have been reported in 0. The incidence of seizures increases dramatically at higher dosages. The risk of seizure appears to be dose-related. Other risk factors are related to patient factors e.
Two cases of elderly patients falling backwards have been attributed to the effects of bupropion on the basal ganglia. Abnormal coordination, dysarthria, hypesthesia, hyperkinesia, hypertonia, vertigo Rare 0. Abnormal electroencephalogram, amnesia, parkinsonism Frequency not reported: Generalized tonic-clonic seizures Postmarketing reports: Weight loss greater than 2. Blood glucose disturbances Very rare less than 0. Dry mouth up to Gastric reflux , gingivitis , gum irritation, increased salivation, inguinal hernia , oral edema , toothache Rare 0.
User Reviews for Wellbutrin XL
At least 14 days should elapse between discontinuation of an MAOI and initiation of bupropion. Wellbutrin glucose disturbances Very rare less than 0. Reactions have been characterized by prurituswellbutrin 150mg xl, urticariaangioedemaand dyspnearequiring medical treatment. Instruct patients if they miss a dose, not to take an extra tablet to make up for the missed dose and to take the next tablet at the regular time 150mg of the dose-related risk of seizure. In addition, in vitro studies wellbutrin that paroxetine, sertraline, norfluoxetine, fluvoxamine, and nelfinavir inhibit the hydroxylation of bupropion, wellbutrin 150mg xl. The dose may be increased to mg 3 times daily after three days and mg 3 times daily after several weeks if the initial response is not adequate. Aggression, bruxismdepersonalization, emotional lability, formal thought disorder, frigidity, mood instability, nightmaresparanoia, paranoid ideation, psychosis, suicidal ideation Rare 0. Although most patients recovered without sequelaedeaths associated with overdoses of bupropion alone have been reported in patients ingesting large doses of the drug. The extent of protein binding of the hydroxybupropion metabolite is similar to that for bupropion, whereas the extent of protein binding of the threohydrobupropion metabolite is about half that of bupropion. A single-dose pharmacokinetic study demonstrated that the disposition of bupropion and its metabolites in elderly subjects was similar to that in younger subjects. The elimination of the major metabolites of bupropion may be reduced by impaired renal function. Advise families and caregivers of patients to 150mg for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt.
Bupropion xl 150 mg (6 days)
Wellbutrin XL Side Effects
Helped to not feel crazy. Hope I feel better soon. Stopped drinking every day, stopped smoking a pack a day, lost weight, motivated and focused. Use In Specific Populations Pregnancy Category C Risk Amlodipine teva price Data from epidemiological studies including pregnant women exposed to bupropion in the first trimester indicate no increased risk of congenital malformations overall. I take mgs XR in the morning. Pharmacokinetics Bupropion is a racemic mixture. Gender A single-dose study involving 12 healthy male and 12 healthy female volunteers revealed no sex-related differences in the pharmacokinetic parameters of bupropion. Such drugs include prochlorperazine Compazinewellbutrin 150mg xl, chlorpromazine Thorazineand other antipsychotic medications of the phenothiazine class. No weight gain at all. I had previously tried Cipralex and Wellbutrin. No overall differences in safety or effectiveness were observed between these subjects and younger subjects. I was a 150mg.